 | • レポートコード：D0GIR-02420 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、大腸がん診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。大腸がん診断の種類別市場規模（便潜血検査、バイオマーカー検査、CRC DNAスクリーニング検査）、用途別市場規模（病院、外来手術センター、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Molecular、Quest Diagnostics、Eiken Chemical、Abbott、Siemens Healthcare、Beckman Coulter、BioTime、Sysmex、Epigenomics、CompanianDx、ExiQon、R-Biopharm、Merck Millipore、Mode Diagnostics、Immunostics、GeneNews、Randox、BioMarCare ・地域別グローバル市場分析 2015年-2020年 ・大腸がん診断の北米市場（アメリカ、カナダ、メキシコ） ・大腸がん診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・大腸がん診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・大腸がん診断の南米市場（ブラジル、アルゼンチン） ・大腸がん診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：便潜血検査、バイオマーカー検査、CRC DNAスクリーニング検査 ・用途別分析：病院、外来手術センター、診断センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Colorectal Cancer Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Colorectal Cancer Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Colorectal Cancer Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Colorectal Cancer Diagnostic market has been segmented into:
Fecal Occult Blood Test
Biomarker Test
CRC DNA Screening Test
By Application, Colorectal Cancer Diagnostic has been segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Colorectal Cancer Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Colorectal Cancer Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Colorectal Cancer Diagnostic market.
The report offers in-depth assessment of the growth and other aspects of the Colorectal Cancer Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Colorectal Cancer Diagnostic Market Share Analysis
Colorectal Cancer Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Colorectal Cancer Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Colorectal Cancer Diagnostic sales, revenue and market share for each player covered in this report.
The major players covered in Colorectal Cancer Diagnostic are:
Abbott Molecular
Quest Diagnostics
Eiken Chemical
Abbott
Siemens Healthcare
Beckman Coulter
BioTime
Sysmex
Epigenomics
CompanianDx
ExiQon
R-Biopharm
Merck Millipore
Mode Diagnostics
Immunostics
GeneNews
Randox
BioMarCare
Table of Contents
1 Colorectal Cancer Diagnostic Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Diagnostic
1.2 Classification of Colorectal Cancer Diagnostic by Type
1.2.1 Global Colorectal Cancer Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Colorectal Cancer Diagnostic Revenue Market Share by Type in 2019
1.2.3 Fecal Occult Blood Test
1.2.4 Biomarker Test
1.2.5 CRC DNA Screening Test
1.3 Global Colorectal Cancer Diagnostic Market by Application
1.3.1 Overview: Global Colorectal Cancer Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Colorectal Cancer Diagnostic Market by Regions
1.4.1 Global Colorectal Cancer Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Colorectal Cancer Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Colorectal Cancer Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Colorectal Cancer Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Molecular
2.1.1 Abbott Molecular Details
2.1.2 Abbott Molecular Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Molecular SWOT Analysis
2.1.4 Abbott Molecular Product and Services
2.1.5 Abbott Molecular Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Quest Diagnostics
2.2.1 Quest Diagnostics Details
2.2.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Quest Diagnostics SWOT Analysis
2.2.4 Quest Diagnostics Product and Services
2.2.5 Quest Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eiken Chemical
2.3.1 Eiken Chemical Details
2.3.2 Eiken Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eiken Chemical SWOT Analysis
2.3.4 Eiken Chemical Product and Services
2.3.5 Eiken Chemical Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Siemens Healthcare SWOT Analysis
2.5.4 Siemens Healthcare Product and Services
2.5.5 Siemens Healthcare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Beckman Coulter
2.6.1 Beckman Coulter Details
2.6.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Beckman Coulter SWOT Analysis
2.6.4 Beckman Coulter Product and Services
2.6.5 Beckman Coulter Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioTime
2.7.1 BioTime Details
2.7.2 BioTime Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioTime SWOT Analysis
2.7.4 BioTime Product and Services
2.7.5 BioTime Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sysmex
2.8.1 Sysmex Details
2.8.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sysmex SWOT Analysis
2.8.4 Sysmex Product and Services
2.8.5 Sysmex Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Epigenomics
2.9.1 Epigenomics Details
2.9.2 Epigenomics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Epigenomics SWOT Analysis
2.9.4 Epigenomics Product and Services
2.9.5 Epigenomics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.10 CompanianDx
2.10.1 CompanianDx Details
2.10.2 CompanianDx Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 CompanianDx SWOT Analysis
2.10.4 CompanianDx Product and Services
2.10.5 CompanianDx Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.11 ExiQon
2.11.1 ExiQon Details
2.11.2 ExiQon Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 ExiQon SWOT Analysis
2.11.4 ExiQon Product and Services
2.11.5 ExiQon Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.12 R-Biopharm
2.12.1 R-Biopharm Details
2.12.2 R-Biopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 R-Biopharm SWOT Analysis
2.12.4 R-Biopharm Product and Services
2.12.5 R-Biopharm Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.13 Merck Millipore
2.13.1 Merck Millipore Details
2.13.2 Merck Millipore Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Merck Millipore SWOT Analysis
2.13.4 Merck Millipore Product and Services
2.13.5 Merck Millipore Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.14 Mode Diagnostics
2.14.1 Mode Diagnostics Details
2.14.2 Mode Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Mode Diagnostics SWOT Analysis
2.14.4 Mode Diagnostics Product and Services
2.14.5 Mode Diagnostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.15 Immunostics
2.15.1 Immunostics Details
2.15.2 Immunostics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Immunostics SWOT Analysis
2.15.4 Immunostics Product and Services
2.15.5 Immunostics Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.16 GeneNews
2.16.1 GeneNews Details
2.16.2 GeneNews Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GeneNews SWOT Analysis
2.16.4 GeneNews Product and Services
2.16.5 GeneNews Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.17 Randox
2.17.1 Randox Details
2.17.2 Randox Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Randox SWOT Analysis
2.17.4 Randox Product and Services
2.17.5 Randox Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.18 BioMarCare
2.18.1 BioMarCare Details
2.18.2 BioMarCare Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 BioMarCare SWOT Analysis
2.18.4 BioMarCare Product and Services
2.18.3 BioMarCare Colorectal Cancer Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Colorectal Cancer Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Colorectal Cancer Diagnostic Players Market Share
3.2.2 Top 10 Colorectal Cancer Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Colorectal Cancer Diagnostic Revenue and Market Share by Regions
4.2 North America Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Colorectal Cancer Diagnostic Revenue by Countries
5.1 North America Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
5.2 USA Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Colorectal Cancer Diagnostic Revenue by Countries
6.1 Europe Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Colorectal Cancer Diagnostic Revenue by Countries
7.1 Asia-Pacific Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
7.2 China Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Colorectal Cancer Diagnostic Revenue by Countries
8.1 South America Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Colorectal Cancer Diagnostic by Countries
9.1 Middle East & Africa Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Colorectal Cancer Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Colorectal Cancer Diagnostic Market Forecast by Type (2019-2024)
10.3 Fecal Occult Blood Test Revenue Growth Rate (2015-2025)
10.4 Biomarker Test Revenue Growth Rate (2015-2025)
10.5 CRC DNA Screening Test Revenue Growth Rate (2015-2025)
11 Global Colorectal Cancer Diagnostic Market Segment by Application
11.1 Global Colorectal Cancer Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Colorectal Cancer Diagnostic Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Colorectal Cancer Diagnostic Market Size Forecast (2021-2025)
12.1 Global Colorectal Cancer Diagnostic Market Size Forecast (2021-2025)
12.2 Global Colorectal Cancer Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Colorectal Cancer Diagnostic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Colorectal Cancer Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Colorectal Cancer Diagnostic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Colorectal Cancer Diagnostic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Molecular Corporate Information, Location and Competitors
Table 6. Abbott Molecular Colorectal Cancer Diagnostic Major Business
Table 7. Abbott Molecular Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Molecular SWOT Analysis
Table 9. Abbott Molecular Colorectal Cancer Diagnostic Product and Solutions
Table 10. Abbott Molecular Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Quest Diagnostics Corporate Information, Location and Competitors
Table 12. Quest Diagnostics Colorectal Cancer Diagnostic Major Business
Table 13. Quest Diagnostics Colorectal Cancer Diagnostic Total Revenue (USD Million) (2018-2019)
Table 14. Quest Diagnostics SWOT Analysis
Table 15. Quest Diagnostics Colorectal Cancer Diagnostic Product and Solutions
Table 16. Quest Diagnostics Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eiken Chemical Corporate Information, Location and Competitors
Table 18. Eiken Chemical Colorectal Cancer Diagnostic Major Business
Table 19. Eiken Chemical Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 20. Eiken Chemical SWOT Analysis
Table 21. Eiken Chemical Colorectal Cancer Diagnostic Product and Solutions
Table 22. Eiken Chemical Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Corporate Information, Location and Competitors
Table 24. Abbott Colorectal Cancer Diagnostic Major Business
Table 25. Abbott Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 26. Abbott SWOT Analysis
Table 27. Abbott Colorectal Cancer Diagnostic Product and Solutions
Table 28. Abbott Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Siemens Healthcare Corporate Information, Location and Competitors
Table 30. Siemens Healthcare Colorectal Cancer Diagnostic Major Business
Table 31. Siemens Healthcare Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 32. Siemens Healthcare SWOT Analysis
Table 33. Siemens Healthcare Colorectal Cancer Diagnostic Product and Solutions
Table 34. Siemens Healthcare Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Beckman Coulter Corporate Information, Location and Competitors
Table 36. Beckman Coulter Colorectal Cancer Diagnostic Major Business
Table 37. Beckman Coulter Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 38. Beckman Coulter SWOT Analysis
Table 39. Beckman Coulter Colorectal Cancer Diagnostic Product and Solutions
Table 40. Beckman Coulter Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. BioTime Corporate Information, Location and Competitors
Table 42. BioTime Colorectal Cancer Diagnostic Major Business
Table 43. BioTime Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 44. BioTime SWOT Analysis
Table 45. BioTime Colorectal Cancer Diagnostic Product and Solutions
Table 46. BioTime Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sysmex Corporate Information, Location and Competitors
Table 48. Sysmex Colorectal Cancer Diagnostic Major Business
Table 49. Sysmex Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 50. Sysmex SWOT Analysis
Table 51. Sysmex Colorectal Cancer Diagnostic Product and Solutions
Table 52. Sysmex Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Epigenomics Corporate Information, Location and Competitors
Table 54. Epigenomics Colorectal Cancer Diagnostic Major Business
Table 55. Epigenomics Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 56. Epigenomics SWOT Analysis
Table 57. Epigenomics Colorectal Cancer Diagnostic Product and Solutions
Table 58. Epigenomics Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. CompanianDx Corporate Information, Location and Competitors
Table 60. CompanianDx Colorectal Cancer Diagnostic Major Business
Table 61. CompanianDx Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 62. CompanianDx SWOT Analysis
Table 63. CompanianDx Colorectal Cancer Diagnostic Product and Solutions
Table 64. CompanianDx Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. ExiQon Corporate Information, Location and Competitors
Table 66. ExiQon Colorectal Cancer Diagnostic Major Business
Table 67. ExiQon Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 68. ExiQon SWOT Analysis
Table 69. ExiQon Colorectal Cancer Diagnostic Product and Solutions
Table 70. ExiQon Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. R-Biopharm Corporate Information, Location and Competitors
Table 72. R-Biopharm Colorectal Cancer Diagnostic Major Business
Table 73. R-Biopharm Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 74. R-Biopharm SWOT Analysis
Table 75. R-Biopharm Colorectal Cancer Diagnostic Product and Solutions
Table 76. R-Biopharm Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Merck Millipore Corporate Information, Location and Competitors
Table 78. Merck Millipore Colorectal Cancer Diagnostic Major Business
Table 79. Merck Millipore Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 80. Merck Millipore SWOT Analysis
Table 81. Merck Millipore Colorectal Cancer Diagnostic Product and Solutions
Table 82. Merck Millipore Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Mode Diagnostics Corporate Information, Location and Competitors
Table 84. Mode Diagnostics Colorectal Cancer Diagnostic Major Business
Table 85. Mode Diagnostics Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 86. Mode Diagnostics SWOT Analysis
Table 87. Mode Diagnostics Colorectal Cancer Diagnostic Product and Solutions
Table 88. Mode Diagnostics Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Immunostics Corporate Information, Location and Competitors
Table 90. Immunostics Colorectal Cancer Diagnostic Major Business
Table 91. Immunostics Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 92. Immunostics SWOT Analysis
Table 93. Immunostics Colorectal Cancer Diagnostic Product and Solutions
Table 94. Immunostics Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. GeneNews Corporate Information, Location and Competitors
Table 96. GeneNews Colorectal Cancer Diagnostic Major Business
Table 97. GeneNews Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 98. GeneNews SWOT Analysis
Table 99. GeneNews Colorectal Cancer Diagnostic Product and Solutions
Table 100. GeneNews Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Randox Corporate Information, Location and Competitors
Table 102. Randox Colorectal Cancer Diagnostic Major Business
Table 103. Randox Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 104. Randox SWOT Analysis
Table 105. Randox Colorectal Cancer Diagnostic Product and Solutions
Table 106. Randox Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. BioMarCare Colorectal Cancer Diagnostic Type and Application
Table 108. BioMarCare Colorectal Cancer Diagnostic Major Business
Table 109. BioMarCare Colorectal Cancer Diagnostic Total Revenue (USD Million) (2017-2018)
Table 110. BioMarCare SWOT Analysis
Table 111. BioMarCare Colorectal Cancer Diagnostic Product and Solutions
Table 112. BioMarCare Colorectal Cancer Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Global Colorectal Cancer Diagnostic Revenue (Million USD) by Players (2015-2020)
Table 114. Global Colorectal Cancer Diagnostic Revenue Share by Players (2015-2020)
Table 115. Global Colorectal Cancer Diagnostic Revenue (Million USD) by Regions (2015-2020)
Table 116. Global Colorectal Cancer Diagnostic Revenue Market Share by Regions (2015-2020)
Table 117. North America Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
Table 118. North America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Table 119. Europe Colorectal Cancer Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 120. Asia-Pacific Colorectal Cancer Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 121. South America Colorectal Cancer Diagnostic Revenue by Countries (2015-2020)
Table 122. South America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Table 123. Middle East and Africa Colorectal Cancer Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 124. Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Table 125. Global Colorectal Cancer Diagnostic Revenue (Million USD) by Type (2015-2020)
Table 126. Global Colorectal Cancer Diagnostic Revenue Share by Type (2015-2020)
Table 127. Global Colorectal Cancer Diagnostic Revenue Forecast by Type (2021-2025)
Table 128. Global Colorectal Cancer Diagnostic Revenue by Application (2015-2020)
Table 129. Global Colorectal Cancer Diagnostic Revenue Share by Application (2015-2020)
Table 130. Global Colorectal Cancer Diagnostic Revenue Forecast by Application (2021-2025)
Table 131. Global Colorectal Cancer Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Colorectal Cancer Diagnostic Picture
Figure 2. Global Colorectal Cancer Diagnostic Revenue Market Share by Type in 2019
Figure 3. Fecal Occult Blood Test Picture
Figure 4. Biomarker Test Picture
Figure 5. CRC DNA Screening Test Picture
Figure 6. Colorectal Cancer Diagnostic Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Global Colorectal Cancer Diagnostic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Colorectal Cancer Diagnostic Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Colorectal Cancer Diagnostic Revenue Market Share in 2019
Figure 19. Global Top 10 Players Colorectal Cancer Diagnostic Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Colorectal Cancer Diagnostic Revenue Market Share by Regions (2015-2020)
Figure 23. Global Colorectal Cancer Diagnostic Revenue Market Share by Regions in 2018
Figure 24. North America Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 25. Europe Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 27. South America Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 29. North America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 30. North America Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2019
Figure 31. USA Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 32. Canada Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 34. Europe Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2019
Figure 36. Germany Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 37. UK Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 38. France Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 39. Russia Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 40. Italy Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2019
Figure 43. China Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 44. Japan Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 45. Korea Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 46. India Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 48. South America Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 49. South America Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2019
Figure 50. Brazil Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 55. UAE Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Colorectal Cancer Diagnostic Revenue and Growth Rate (2015-2020)
Figure 58. Global Colorectal Cancer Diagnostic Revenue Share by Type (2015-2020)
Figure 59. Global Colorectal Cancer Diagnostic Revenue Share by Type in 2019
Figure 60. Global Colorectal Cancer Diagnostic Market Share Forecast by Type (2021-2025)
Figure 61. Global Fecal Occult Blood Test Revenue Growth Rate (2015-2020)
Figure 62. Global Biomarker Test Revenue Growth Rate (2015-2020)
Figure 63. Global CRC DNA Screening Test Revenue Growth Rate (2015-2020)
Figure 64. Global Colorectal Cancer Diagnostic Revenue Share by Application (2015-2020)
Figure 65. Global Colorectal Cancer Diagnostic Revenue Share by Application in 2019
Figure 66. Global Colorectal Cancer Diagnostic Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Colorectal Cancer Diagnostic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Colorectal Cancer Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Colorectal Cancer Diagnostic Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
Figure 74. Europe Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
Figure 76. South America Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Colorectal Cancer Diagnostic Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
大腸がん診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- 大腸がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 9118.8 million by 2025, from USD 8386.1 million in 2019. The Colorectal Cancer …
- 転移性大腸がん手術の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastat…
- 大腸がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Colorectal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 肛門・結腸直腸癌の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Anal and Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anal and Colorecta…